Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$4,422,951
+$87,601 QoQ
Shares Held
28,222
-0.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#284
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Haverford Trust Co holds $537,648,653 across 11 Drug Manufacturers - General names. NVS ranks #7 (0.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
996,670 | $253,124,279 | |
| 2 | LLY |
ELI LILLY & Co
|
165,960 | $199,057,419 | |
| 3 | MRK |
Merck & Co., Inc.
|
272,415 | $35,005,327 | |
| 4 | ABBV |
AbbVie Inc.
|
80,847 | $20,344,339 | |
| 5 | AMGN |
Amgen Inc
|
29,763 | $10,777,777 | |
| 6 | PFE |
Pfizer Inc
|
381,414 | $9,184,449 | |
| 7 | NVS |
Novartis AG
This page
|
28,222 | $4,422,951 | |
| 8 | GSK |
GSK plc
|
47,770 | $2,504,103 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,422,951 | 28,222 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $4,335,350 | 28,382 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $3,913,026 | 28,382 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $3,702,801 | 28,874 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $4,506,170 | 37,238 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $4,154,302 | 37,265 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $3,691,844 | 37,939 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $4,304,393 | 37,423 | Shares | Defined | 2024-11-05 | |
| 2024-06-30 | $3,904,633 | 36,677 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $3,660,553 | 37,843 | Shares | Defined | 2024-05-02 | |
| 2023-12-31 | $3,515,371 | 34,816 | Shares | Defined | 2024-02-08 | |
| 2023-09-30 | $3,181,087 | 31,230 | Shares | Defined | 2023-11-09 | |
| 2023-06-30 | $3,160,400 | 31,319 | Shares | Defined | 2023-08-08 | |
| 2023-03-31 | $3,101,872 | 33,716 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $2,910,751 | 32,085 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,470,248 | 32,499 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,747,140 | 32,499 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $2,857,578 | 32,565 | Shares | Defined | 2022-05-05 | |
| 2021-12-31 | $3,727,096 | 42,610 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $3,484,645 | 42,610 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $4,569,299 | 50,080 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $4,084,234 | 47,780 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $3,658,501 | 38,743 | Shares | Defined | 2021-02-05 | |
| 2020-09-30 | $3,003,859 | 34,543 | Shares | Defined | 2020-11-10 | |
| 2020-06-30 | $3,074,018 | 35,196 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $2,900,261 | 35,176 | Shares | Defined | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||